Achillion to Present at Two Upcoming Investor Conferences

Achillion to Present at Two Upcoming Investor Conferences NEW HAVEN, Conn., March 1, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that members of the executive team will provide a corporate update at the following upcoming investor conferences: Click here for release.

You are subscribed to Achillion Pharmaceuticals Investor Relations'' e-mail alerts as clotito+biotechdash@gmail.com. To update your e-mail and alert preferences, please click here. To unsubscribe, please click here. Achillion Pharmaceuticals 300 George St. , New Haven, CT 06511 Service provided by Shareholder.com